Skip to main content
SpringerLink
Log in

Skewed immunological balance between Th17 (CD4+IL17A+) and Treg (CD4+CD25+FOXP3+) cells in human oral squamous cell carcinoma

  • Original Paper
  • Published:
Cellular Oncology Aims and scope Submit manuscript

Abstract

Background

Several studies have documented modulation of Th17 and T regulatory (Treg) cells in various human malignancies which may vary with the type and extent of the disease. However, such data in patients with oral cancer is scarce and hence the current study was designed to elaborate the immunological balance between these two T cell subsets in oral cancer.

Methods and results

We analyzed various T cell subsets in the peripheral blood of 45 oral squamous cell carcinoma (OSCC) patients and 40 healthy volunteers. We found that, compared with the healthy controls, patients had a significantly (p < 0.0001) higher proportion of both Th17 (CD4+IL17A+) and Treg (CD4+CD25+FOXP3+) cells, which further showed a reciprocal balance in relation to clinico-pathological parameters in patients. We also detected a circulating CD8+ subset of these cells in both patients and healthy controls, although the difference between the two groups was statistically insignificant. Higher frequencies of Th17 cells were found in patients with early stages and without lymph node involvement, while an increased prevalence of Tregs was associated with higher clinical stages and lymph node involvement. Moreover, Th17 cells were quantitatively and positively correlated to CD4+T and CD8+T cells and inversely correlated with Tregs. Contrarily, Tregs showed a negative association with CD4+T and CD8+T cells.

Conclusions

Our results suggest an increase in Th17/Tregs ratio in early stages and a decrease in this ratio in higher stages of oral cancer. Such counter regulation of Th17 and Tregs may be a significant prognostic factor in oral cancer patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. J. Ferlay, H.R. Shin, F. Bray, D. Forman, C. Mathers, D.M. Parkin, GLOBOCAN 2008 v1.2, Cancer Incidence and Mortality Worldwide: IARC Cancer Base No. 10 (Lyon, France: International Agency for Research on Cancer, 2010). Available from: http://globocan.iarc.fr. Accessed on 15 March 2012

  2. M.C. Chang, C.P. Chiang, C.L. Lin, J.J. Lee, L.J. Hahn, J.H. Jeng, Cell-mediated immunity and head and neck cancer: with special emphasis on betel quid chewing habit. Oral Oncol. 41, 757–775 (2005)

    Article  PubMed  CAS  Google Scholar 

  3. S.N. Das, N.N. Khanna, S. Khanna, In vivo and in vitro observation of cellular immune parameters in squamous cell carcinoma of the oral cavity and its correlation with tumor load and prognosis. Cancer Invest. 4, 207–216 (1986)

    Article  PubMed  CAS  Google Scholar 

  4. T.P. Wustrow, C.G. Mahnke, Causes of immunosuppression in squamous cell carcinoma of the head and neck. Anticancer Res. 16, 2433–2468 (1996)

    PubMed  CAS  Google Scholar 

  5. E.Y. Woo, H. Yeh, C.S. Chu, K. Schlienger, R.G. Carroll, J.L. Riley, L.R. Kaiser, C.H. June, Cutting edge: Regulatory T cells from lung cancer patients directly inhibit autologous T cell proliferation. J. Immunol. 168, 4272–4276 (2002)

    PubMed  CAS  Google Scholar 

  6. U.K. Liyanage, T.T. Moore, H.G. Joo, Y. Tanaka, V. Herrmann, G. Doherty, J.A. Drebin, S.M. Strasberg, T.J. Eberlein, P.S. Goedegebuure, D.C. Linehan, Prevalence of regulatory T cells is increased in peripheral blood and tumor microenvironment of patients with pancreas or breast adenocarcinoma. J. Immunol. 169, 2756–2761 (2002)

    PubMed  CAS  Google Scholar 

  7. A.M. Miller, K. Lundberg, V. Ozenci, A.H. Banham, M. Hellström, L. Egevad, P. Pisa, CD4 + CD25high T cells are enriched in the tumor and peripheral blood of prostate cancer patients. J. Immunol. 177, 7398–7405 (2006)

    PubMed  CAS  Google Scholar 

  8. L.A. Ormandy, T. Hillemann, H. Wedemeyer, M.P. Manns, T.F. Greten, F. Korangy, Increased populations of regulatory T cells in peripheral blood of patients with hepatocellular carcinoma. Cancer Res. 65, 2457–2464 (2005)

    Article  PubMed  CAS  Google Scholar 

  9. T.J. Curiel, G. Coukos, L. Zou, X. Alvarez, P. Cheng, P. Mottram, M. Evdemon-Hogan, J.R. Conejo-Garcia, L. Zhang, M. Burow, Y. Zhu, S. Wei, I. Kryczek, B. Daniel, A. Gordon, L. Myers, A. Lackner, M.L. Disis, K.L. Knutson, L. Chen, W. Zou, Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival. Nat. Med. 10, 942–949 (2004)

    Article  PubMed  CAS  Google Scholar 

  10. A. Bamias, V. Koutsoukou, E. Terpos, M.L. Tsiatas, C. Liakos, O. Tsitsilonis, A. Rodolakis, Z. Voulgaris, G. Vlahos, T. Papageorgiou, G. Papatheodoridis, A. Archimandritis, A. Antsaklis, M.A. Dimopoulos, Correlation of NK T-like CD3 + CD56+ cells and CD4 + CD25 + (hi) regulatory T cells with VEGF and TNFalpha in ascites from advanced ovarian cancer: Association with platinum resistance and prognosis in patients receiving first-line, platinum-based chemotherapy. Gynecol. Oncol. 108, 421–427 (2008)

    Article  PubMed  CAS  Google Scholar 

  11. J. Shimizu, S. Yamazaki, S. Sakaguchi, Induction of tumor immunity by removing CD25 + CD4+ T cells: a common basis between tumor immunity and autoimmunity. J. Immunol. 163, 5211–5218 (1999)

    PubMed  CAS  Google Scholar 

  12. I. Kryczek, M. Banerjee, P. Cheng, L. Vatan, W. Szeliga, S. Wei, E. Huang, E. Finlayson, D. Simeone, T.H. Welling, A. Chang, G. Coukos, R. Liu, W. Zou, Phenotype, distribution, generation, and functional and clinical relevance of Th17 cells in the human tumor environments. Blood 114, 1141–1149 (2009)

    Article  PubMed  CAS  Google Scholar 

  13. X. Su, J. Ye, E.C. Hsueh, Y. Zhang, D.F. Hoft, G. Peng, Tumor microenvironments direct the recruitment and expansion of human Th17 cells. J. Immunol. 184, 1630–1641 (2010)

    Article  PubMed  CAS  Google Scholar 

  14. J.P. Zhang, J. Yan, J. Xu, X.H. Pang, M.S. Chen, L. Li, C. Wu, S.P. Li, L. Zheng, Increased intratumoral IL-17-producing cells correlate with poor survival in hepatocellular carcinoma patients. J. Hepatol. 50, 980–989 (2009)

    Article  PubMed  CAS  Google Scholar 

  15. K.S. Sfanos, T.C. Bruno, C.H. Maris, L. Xu, C.J. Thoburn, A.M. DeMarzo, A.K. Meeker, W.B. Isaacs, C.G. Drake, Phenotypic analysis of prostate-infiltrating lymphocytes reveals TH17 and Treg skewing. Clin. Cancer Res. 14, 3254–3261 (2008)

    Article  PubMed  CAS  Google Scholar 

  16. K. Koyama, H. Kagamu, S. Miura, T. Hiura, T. Miyabayashi, R. Itoh, H. Kuriyama, H. Tanaka, J. Tanaka, H. Yoshizawa, K. Nakata, F. Gejyo, Reciprocal CD4+ T-cell balance of effector CD62Llow CD4+ and CD62LhighCD25+ CD4+ regulatory T cells in small cell lung cancer reflects disease stage. Clin. Cancer Res. 14, 6770–6779 (2008)

    Article  PubMed  CAS  Google Scholar 

  17. Z.Z. Yang, A.J. Novak, S.C. Ziesmer, T.E. Witzig, S.M. Ansell, Malignant B cells skew the balance of regulatory T cells and TH17 cells in B-cell non-Hodgkin’s lymphoma. Cancer Res. 69, 5522–5530 (2009)

    Article  PubMed  CAS  Google Scholar 

  18. C. Horlock, B. Stott, P.J. Dyson, M. Morishita, R.C. Coombes, P. Savage, J. Stebbing, The effects of transtuzumab on the CD4 + CD25 + FOXP3+ and CD4 + IL17A + T-cell axis in patients with breast cancer. Br. J. Cancer 100, 1061–1067 (2009)

    Article  PubMed  CAS  Google Scholar 

  19. I. Kryczek, S. Wei, L. Zou, S. Altuwaijri, W. Szeliga, J. Kolls, A. Chang, W. Zou, Cutting edge: Th17 and regulatory T cell dynamics and the regulation by IL-2 in the tumor microenvironment. J. Immunol. 178, 6730–6733 (2007)

    PubMed  CAS  Google Scholar 

  20. E.S. Hwang, Transcriptional regulation of T helper 17 cell differentiation. Yonsei Med. J. 51, 484–491 (2010)

    Article  PubMed  CAS  Google Scholar 

  21. J. Lohr, B. Knoechel, D. Caretto, A.K. Abbas, Balance of Th1 and Th17 effector and peripheral regulatory T cells. Microbes Infect. 11, 589–593 (2009)

    Article  PubMed  CAS  Google Scholar 

  22. E. Bettelli, M. Oukka, V.K. Kuchroo, T(H)-17 cells in the circle of immunity and autoimmunity. Nat. Immunol. 8, 345–350 (2007)

    Article  PubMed  CAS  Google Scholar 

  23. A. O’Garra, P. Vieira, Regulatory T cells and mechanisms of immune system control. Nat. Med. 10, 801–805 (2004)

    Article  PubMed  Google Scholar 

  24. C. Dong, TH17 cells in development: an updated view of their molecular identity and genetic programming. Nat. Rev. Immunol. 8, 337–348 (2008)

    Article  PubMed  CAS  Google Scholar 

  25. A. Agarwal, M. Rani, G.K. Saha, T.M. Valarmathi, S. Bahadur, B.K. Mohanti, S.N. Das, Disregulated expression of the Th2 cytokine gene in patients with intraoral squamous cell carcinoma. Immunol. Invest. 32, 17–30 (2003)

    Article  PubMed  CAS  Google Scholar 

  26. C.S. Hinrichs, A. Kaiser, C.M. Paulos, L. Cassard, L. Sanchez-Perez, B. Heemskerk, C. Wrzesinski, Z.A. Borman, P. Muranski, N.P. Restifo, Type 17 CD8+ T cells display enhanced antitumor immunity. Blood 114, 596–599 (2009)

    Article  PubMed  CAS  Google Scholar 

  27. Y. Miyahara, K. Odunsi, W. Chen, G. Peng, J. Matsuzaki, R.F. Wang, Generation and regulation of human CD4+ IL-17-producing T cells in ovarian cancer. Proc Natl Acad of Sci USA 105, 15505–15510 (2008)

    Article  CAS  Google Scholar 

  28. J.J. Lee, Y.L. Chang, W.L. Lai, J.Y. Ko, M.Y. Kuo, C.P. Chiang, M. Azuma, C.W. Chen, J.S. Chia, Increased prevalence of interleukin-17-producing CD4(+) tumor infiltrating lymphocytes in human oral squamous cell carcinoma. Head Neck 33, 1301–1308 (2011)

    Article  PubMed  CAS  Google Scholar 

  29. P. Muranski, A. Boni, P.A. Antony, L. Cassard, K.R. Irvine, A. Kaiser, C.M. Paulos, D.C. Palmer, C.E. Touloukian, K. Ptak, L. Gattinoni, C. Wrzesinski, C.S. Hinrichs, K.W. Kerstann, L. Feigenbaum, C.C. Chan, N.P. Restifo, Tumor-specific Th17-polarized cells eradicate large established melanoma. Blood 112, 362–373 (2008)

    Article  PubMed  CAS  Google Scholar 

  30. N. Martin-Orozco, P. Muranski, Y. Chung, X.O. Yang, T. Yamazaki, S. Lu, P. Hwu, N.P. Restifo, W.W. Overwijk, C. Dong, T helper 17 cells promote cytotoxic T cell activation in tumor immunity. Immunity 31, 787–798 (2009)

    Article  PubMed  CAS  Google Scholar 

  31. M. Numasaki, J. Fukushi, M. Ono, S.K. Narula, P.J. Zavodny, T. Kudo, P.D. Robbins, H. Tahara, M.T. Lotze, Interleukin-17 promotes angiogenesis and tumor growth. Blood 101, 2620–2627 (2003)

    Article  PubMed  CAS  Google Scholar 

  32. M. Pelletier, L. Maggi, A. Micheletti, E. Lazzeri, N. Tamassia, C. Costantini, L. Cosmi, C. Lunardi, F. Annunziato, S. Romagnani, M.A. Cassatella, Evidence for a cross-talk between human neutrophils and Th17 cells. Blood 115, 335–343 (2010)

    Article  PubMed  CAS  Google Scholar 

  33. L. Wang, T. Yi, M. Kortylewski, D.M. Pardoll, D. Zeng, H. Yu, IL-17 can promote tumor growth through an IL-6–Stat3 signaling pathway. J. Exp. Med. 206, 1457–1464 (2009)

    Article  PubMed  CAS  Google Scholar 

  34. W. Zou, N.P. Restifo, T(H)17 cells in tumour immunity and immunotherapy. Nat. Rev. Immunol. 10, 248–256 (2010)

    Article  PubMed  CAS  Google Scholar 

  35. X.O. Yang, R. Nurieva, G.J. Martinez, H.S. Kang, Y. Chung, B.P. Pappu, B. Shah, S.H. Chang, K.S. Schluns, S.S. Watowich, X.H. Feng, A.M. Jetten, C. Dong, Molecular antagonism and plasticity of regulatory and inflammatory T cell programs. Immunity 29, 44–56 (2008)

    Article  PubMed  CAS  Google Scholar 

  36. K.M. Elias, A. Laurence, T.S. Davidson, G. Stephens, Y. Kanno, E.M. Shevach, J.J. O'Shea, Retinoic acid inhibits Th17 polarization and enhances FoxP3 expression through a Stat-3/Stat-5 independent signaling pathway. Blood 111, 1013–1020 (2008)

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgements

We are grateful to the patients and healthy donors for their participation in this study. This study was supported by Department of Biotechnology (DBT), Ministry of Science & Technology, Govt. of India. PG is a recipient of JRF from CSIR while AKS, GAQ, SU received fellowships from DBT.

Author information

Authors and Affiliations

  1. Departments of Biotechnology, All India Institute of Medical Sciences, Ansari Nagar, New Delhi, 110029, India

    Poonam Gaur, Gulam Abdul Qadir, Shilpy Upadhyay, Avadhesh Kumar Singh & Satya Narayan Das

  2. Surgical Oncology, BRA-IRCH, All India Institute of Medical Sciences, Ansari Nagar, New Delhi, 110029, India

    Nootan Kumar Shukla

Authors
  1. Poonam Gaur
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Gulam Abdul Qadir
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Shilpy Upadhyay
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Avadhesh Kumar Singh
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Nootan Kumar Shukla
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Satya Narayan Das
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Satya Narayan Das.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Gaur, P., Qadir, G.A., Upadhyay, S. et al. Skewed immunological balance between Th17 (CD4+IL17A+) and Treg (CD4+CD25+FOXP3+) cells in human oral squamous cell carcinoma. Cell Oncol. 35, 335–343 (2012). https://doi.org/10.1007/s13402-012-0093-5

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13402-012-0093-5

Keywords

Search

Navigation